Findings

What do systematic reviews say?

8 questions · 8 findings · 1 reviews · Stroke

No studies found 3 · 37.5%GRADE not reported 0 · 0%Very low 1 · 12.5%Low 4 · 50%Moderate 0 · 0%High 0 · 0%

Outcomes (measurement) · asymptomatic carotid stenosis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Neurological impairment · asymptomatic carotid stenosis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ipsilateral major or disabling stroke · asymptomatic carotid stenosis

Antiplatelet agent showed no clear difference in ipsilateral major or disabling stroke (CT scan or MRI) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 1.08 [0.47, 2.47]
1 study · 372 participants
Low

Stroke‐related mortality · asymptomatic carotid stenosis

Antiplatelet agent showed no clear difference in stroke‐related mortality (CT scan or MRI) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 1.4 [0.54, 3.59]
1 study · 372 participants
Low

Major bleeding · asymptomatic carotid stenosis

It is very uncertain whether antiplatelet agent changes major bleeding (not reported) compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 0.98 [0.06, 15.53]
1 study · 372 participants
Very low

Progression of carotid stenosis · asymptomatic carotid stenosis

Antiplatelet agent showed no clear difference in progression of carotid stenosis (DUS/every 6 months) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 1.16 [0.79, 1.71]
1 study · 372 participants
Low

Adverse events (not reported) · asymptomatic carotid stenosis

Antiplatelet agent showed no clear difference in adverse events (not reported) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 0.81 [0.41, 1.59]
1 study · 372 participants
Low

Quality of life · asymptomatic carotid stenosis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found